ICON PLC (ICLR) stock
ICLRNasdaqServices-Commercial Physical & Biological Research
$195.16+0.14 (+0.07%)
Close on Nov 18, 2026Market cap $14.94BP/E 33.6Yield –
ICON revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
ICON's revenue for the twelve months ending Sep 30, 2026 was $8.23B, up 0.4% year over year. For fiscal 2025 it was $8.25B, up 0.8% from the year before. Over ten years it grew 18.0% a year on average. The highest annual figure on record is $8.25B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.25B | +0.8% |
| FY2024 | Dec 31, 2024 | $8.19B | +1.7% |
| FY2023 | Dec 31, 2023 | $8.05B | +4.1% |
| FY2022 | Dec 31, 2022 | $7.74B | +41.2% |
| FY2021 | Dec 31, 2021 | $5.48B | +95.9% |
| FY2020 | Dec 31, 2020 | $2.80B | -0.3% |
| FY2019 | Dec 31, 2019 | $2.81B | +8.1% |
| FY2018 | Dec 31, 2018 | $2.60B | +47.6% |
| FY2017 | Dec 31, 2017 | $1.76B | +5.5% |
| FY2016 | Dec 31, 2016 | $1.67B | +5.8% |
| FY2015 | Dec 31, 2015 | $1.57B | +4.8% |
| FY2014 | Dec 31, 2014 | $1.50B | +12.5% |
| FY2013 | Dec 31, 2013 | $1.34B | +19.8% |
| FY2012 | Dec 31, 2012 | $1.12B | +17.9% |
| FY2011 | Dec 31, 2011 | $945.73M | +5.1% |
| FY2010 | Dec 31, 2010 | $900.04M | +1.4% |
| FY2009 | Dec 31, 2009 | $887.61M | +2.6% |
| FY2008 | Dec 31, 2008 | $865.25M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.02B | -2.9% |
| Q2 FY2026 | Jun 30, 2026 | $2.06B | +1.2% |
| Q1 FY2026 | Mar 31, 2026 | $2.03B | +0.9% |
| Q4 FY2025 | Dec 31, 2025 | $2.11B | +2.5% |
| Q3 FY2025 | Sep 30, 2025 | $2.08B | +2.1% |
| Q2 FY2025 | Jun 30, 2025 | $2.04B | -0.1% |
| Q1 FY2025 | Mar 31, 2025 | $2.02B | -1.4% |
| Q4 FY2024 | Dec 31, 2024 | $2.06B | +1.0% |
| Q3 FY2024 | Sep 30, 2024 | $2.04B | +0.1% |
| Q2 FY2024 | Jun 30, 2024 | $2.04B | +1.7% |
| Q1 FY2024 | Mar 31, 2024 | $2.04B | +3.9% |
| Q4 FY2023 | Dec 31, 2023 | $2.04B | +4.0% |
| Q3 FY2023 | Sep 30, 2023 | $2.04B | +5.0% |
| Q2 FY2023 | Jun 30, 2023 | $2.01B | +3.8% |
| Q1 FY2023 | Mar 31, 2023 | $1.97B | +3.4% |
| Q4 FY2022 | Dec 31, 2022 | $1.96B | +4.1% |
| Q3 FY2022 | Sep 30, 2022 | $1.94B | +4.1% |
| Q2 FY2022 | Jun 30, 2022 | $1.94B | +122.1% |
| Q1 FY2022 | Mar 31, 2022 | $1.90B | +121.6% |
| Q4 FY2021 | Dec 31, 2021 | $1.89B | +148.0% |
| Q3 FY2021 | Sep 30, 2021 | $1.87B | +166.0% |
| Q2 FY2021 | Jun 30, 2021 | $871.16M | +40.5% |
| Q1 FY2021 | Mar 31, 2021 | $858.20M | +20.0% |
| Q4 FY2020 | Dec 31, 2020 | $760.23M | +4.8% |
| Q3 FY2020 | Sep 30, 2020 | $701.73M | -1.2% |
| Q2 FY2020 | Jun 30, 2020 | $620.23M | -10.8% |
| Q1 FY2020 | Mar 31, 2020 | $715.10M | +6.0% |
| Q4 FY2019 | Dec 31, 2019 | $725.41M | +6.8% |
| Q3 FY2019 | Sep 30, 2019 | $710.44M | +8.5% |
| Q2 FY2019 | Jun 30, 2019 | $695.14M | +8.3% |
| Q1 FY2019 | Mar 31, 2019 | $674.85M | +8.8% |
| Q4 FY2018 | Dec 31, 2018 | $679.03M | +49.2% |
| Q3 FY2018 | Sep 30, 2018 | $655.02M | +48.8% |
| Q2 FY2018 | Jun 30, 2018 | $641.61M | +48.9% |
| Q1 FY2018 | Mar 31, 2018 | $620.13M | +43.6% |
| Q4 FY2017 | Dec 31, 2017 | $455.14M | +4.6% |
| Q3 FY2017 | Sep 30, 2017 | $440.32M | – |
| Q2 FY2017 | Jun 30, 2017 | $431.02M | – |
| Q1 FY2017 | Mar 31, 2017 | $431.95M | – |
| Q4 FY2016 | Dec 31, 2016 | $435.13M | – |
See a number that looks wrong?